- Page 1 and 2: Immunotherapy Safety for the Primar
- Page 3 and 4: Welcome to “Immunotherapy Safety
- Page 5 and 6: Click the ⌧ next to the topic to
- Page 7: Immunotherapy at Remote Sites Stand
- Page 11 and 12: How Does Immunotherapy Work? • De
- Page 13 and 14: Who Benefits? •Those with… - Al
- Page 15 and 16: Immunotherapy Efficacy • Effectiv
- Page 17 and 18: Not Efficacious For… • Atopic d
- Page 19 and 20: The Extracts/Vaccines • Bioequiva
- Page 21 and 22: Lots of Numbers! Vial v/v W/V (exam
- Page 23 and 24: Immunotherapy Phases • Maintenanc
- Page 25 and 26: Reaction Prevention - Avoidance •
- Page 27 and 28: Reaction Therapy - BLS+ Level • T
- Page 29 and 30: Treatment Guidelines • Treatment
- Page 31 and 32: Frequency of Systemic Reactions •
- Page 33 and 34: Immunotherapy Safety • To lessen
- Page 35 and 36: Immunotherapy Safety • To lessen
- Page 37 and 38: Immunotherapy Safety • After Inje
- Page 39 and 40: Immunotherapy Safety • Equipment:
- Page 41 and 42: What To Expect (Demand) from the Al
- Page 43 and 44: Summary • Risk factors for advers
- Page 45: End of Selection Go to Bookmarks &
- Page 48 and 49: • Allergen immunotherapy (allergy
- Page 50 and 51: BEFORE EACH SHOT!!! • Screen pati
- Page 52 and 53: instruct patient to report any abno
- Page 54 and 55: • Negative (swelling up to 15mm;
- Page 56 and 57: Epi-Pen Adult Epi-Pen JR TwinJect
- Page 58 and 59:
How to dilute from available vials:
- Page 60 and 61:
Vial v/v W/V AU/ML BAU/ML 5 Red 4 G
- Page 62 and 63:
Summary • Pull the patient's alle
- Page 64 and 65:
End of Selection Go to Bookmarks &
- Page 66 and 67:
a. Medical conditions that reduce t
- Page 68 and 69:
Allergen immunotherapy should be gi
- Page 70 and 71:
patient’s peak expiratory flow ra
- Page 72 and 73:
7. Neilson L, Johnsen C, Mosbech H,
- Page 74 and 75:
Click the ⌧ next to the heading t
- Page 76 and 77:
a common practice to alternate the
- Page 78 and 79:
ALLERGY IMMUNOTHERAPY (AIT) PROBLEM
- Page 80 and 81:
End of Selection Go to Bookmarks &
- Page 82 and 83:
10. Those patients having their dos
- Page 84 and 85:
SPECIFIC INSTRUCTIONS A. PHYSICIAN
- Page 86 and 87:
ALLERGY IMMUNOTHERAPY RECORD NNMC,
- Page 88 and 89:
Immunotherapy Pre-Injection Questio
- Page 90 and 91:
Aeroallergen Dose Adjustment Schedu
- Page 92 and 93:
NATIONAL NAVAL MEDICAL CENTER: Alle
- Page 94 and 95:
ONGOING COMPETENCY ASSESSMENT OF UN
- Page 96 and 97:
End of Selection Go to Bookmarks &
- Page 98 and 99:
eflecting current robust documentat
- Page 100 and 101:
Allergen immunotherapy: A practice
- Page 102 and 103:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 104 and 105:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 106 and 107:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 108 and 109:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 110 and 111:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 112 and 113:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 114 and 115:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 116 and 117:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 118 and 119:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 120 and 121:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 122 and 123:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 124 and 125:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 126 and 127:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 128 and 129:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 130 and 131:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 132 and 133:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 134 and 135:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 136 and 137:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 138 and 139:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 140 and 141:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 142 and 143:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 144 and 145:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 146 and 147:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 148 and 149:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 150 and 151:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 152 and 153:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 154 and 155:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 156 and 157:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 158 and 159:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 160 and 161:
J ALLERGY CLIN IMMUNOL VOLUME 120,
- Page 162 and 163:
Immunotherapy Safety for the Primar
- Page 164 and 165:
15. A 12 yo male presents for his a
- Page 166 and 167:
Immunotherapy Safety for the Primar
- Page 168 and 169:
Site Under Construction
- Page 170 and 171:
Introduction • “Anaphylaxis”
- Page 172 and 173:
Revised Nomenclature For Anaphylaxi
- Page 174 and 175:
Anaphylaxis* Is Not Rare Estimated
- Page 176 and 177:
Pathophysiology
- Page 178 and 179:
Pathophysiology
- Page 180 and 181:
Pathophysiology • Histamine acts
- Page 182 and 183:
IgE Mediated Reactions • Most Ant
- Page 184 and 185:
Complement-mediated • C5a, C3a, C
- Page 186 and 187:
Unknown Mechanisms • Exercise-ind
- Page 188 and 189:
Anaphylaxis Summary of Signs & Symp
- Page 190 and 191:
Differential Diagnosis • Pulmonar
- Page 192 and 193:
Anaphylaxis Grading Scale II • An
- Page 194 and 195:
Laboratory Studies • IgE antibodi
- Page 196 and 197:
Guidelines for Treatment • Treatm
- Page 198 and 199:
Guidelines for Treatment • Treatm
- Page 200 and 201:
How the Allergist/Immunologist Can
- Page 202 and 203:
Summary • Anaphylaxis: release of
- Page 204 and 205:
ANAPHYLAXIS • First reported case
- Page 206 and 207:
4) Hymenoptera stings Although almo
- Page 208 and 209:
• Sulfites are added to all the b
- Page 210 and 211:
mastocytosis on bone marrow biopsy.
- Page 212 and 213:
Antihistamines H1 antihistamines (B
- Page 214:
End of Selection Go to Bookmarks &
- Page 224 and 225:
The diagnosis and management of ana
- Page 226 and 227:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 228 and 229:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 230 and 231:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 232 and 233:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 234 and 235:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 236 and 237:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 238 and 239:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 240 and 241:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 242 and 243:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 244 and 245:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 246 and 247:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 248 and 249:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 250 and 251:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 252 and 253:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 254 and 255:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 256 and 257:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 258 and 259:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 260 and 261:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 262 and 263:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 264 and 265:
J ALLERGY CLIN IMMUNOL VOLUME 115,
- Page 267 and 268:
End of Selection Go to Bookmarks &
- Page 269 and 270:
c. The patient will be counseled co
- Page 271 and 272:
End of Selection Go to Bookmarks &
- Page 273 and 274:
skin testing typically is performed
- Page 275 and 276:
TABLE 3 Required Information on Vac
- Page 277 and 278:
TABLE 6 Checklist for Safe Vaccine
- Page 279 and 280:
Strength of Recommendations Key cli
- Page 281 and 282:
Original articles Evaluation of nea
- Page 283 and 284:
J ALLERGY CLIN IMMUNOL VOLUME 117,
- Page 285 and 286:
J ALLERGY CLIN IMMUNOL VOLUME 117,
- Page 287 and 288:
J ALLERGY CLIN IMMUNOL VOLUME 117,
- Page 289 and 290:
Allergy Treatment Record Review Cha
- Page 291 and 292:
References Acknowledgment: Linda Co